Sirnax

US-based, early-stage biotech developing siRNA therapeutics for rare lymphomas

placeAnn Arbor, Michigan, United States calendar_todayFounded 2012 language sirnax.com

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon